Cortical Bone Assessment Using Ultrasonic Guided Waves: Towards a Robust Clinical Measurement (BDATChile)

Cortical Bone Assessment Using Ultrasonic Guided Waves: Towards a Robust Clinical

Osteoporosis is a skeletal disease leading to bone fragility and increasing the risk of fractures and still remains a major public health problem worldwide. Therefore it is crucial to prevent severe fractures responsible for excess of mortality and considerable morbidity. Patient at risk of fractures are currently identified as having osteoporosis using Dual-energy X-ray Absorptiometry (DXA), assessing the areal or projected Bone Mineral Density (aBMD g.cm-2). In Chile, the hip fracture occurrence is very similar to the international incidence. Due to the demographic and epidemiological transition, the number of hip fracture for patient older than 50 year, is expected to severely increase from about 6.500 (2007) to 30.000 (2050) without adequate preventive and / or therapeutic measures.

Even if DXA remains the current gold standard, it is limited by the difficulty to set a threshold in the BMD distribution for osteoporosis diagnosis. Moreover, some medical conditions (chronic kidney disease, diabetes) or drugs (glucocorticoids) are associated with an increase of fracture risk without a BMD decrease. Quantitative ultrasound (QUS) have the advantages of portability, low cost, absence of radiation and need for a radiographic technologist or designated room, and are sensitive to both elasticity and geometry of the medium explored by the waves. Among QUS techniques, axial transmission (AT) is a technique for which transducers are aligned along the bone axis. Measured ultrasonic guided waves, associated with an appropriate waveguide model have the potential to yield estimates of material and/or geometrical cortical properties. In vivo combined estimation of both cortical thickness and porosity has been proposed using bidirectional axial transmission (BDAT). BDAT measurement has been recently validated on ex vivo specimen (radius and tibia) and has been tested in a pilot clinical study, in which cortical porosity measured at the one-third distal radius has been found as discriminant of low trauma fractures as DXA. Cortical porosity is increasingly recognized as a major contributor to bone fragility.

The hypothesis underlying this project are that (1) it is possible to obtain robust and accurate estimates of cortical thickness and porosity using an improved BDAT device and (2) these estimates are of clinical interest in the context of osteoporosis in elderly. Moreover, novel parameters obtained from automatic classification tools will be tested.

Study Overview

• Status: Completed
• Conditions: Osteoporotic Fractures
• Intervention / Treatment: Other: Bone measurement by DXA and ultrasound

Detailed Description

The purpose of this investigation is to determine if there are differences in the quantities of cortical bone (thickness and porosity) as well as the new parameters measured by BDAT at both forearm and leg, between patients with recent non traumatic fracture and controls.

Results will be compared to the current gold standard dual-energy X-ray absorptiometry (DXA) of the hip, spine and forearm, obtained from all subjects. The BDAT device with the improved interface will be tested in a clinical environment by clinical operators on:

• minimum sample size per group: 25 for cases and controls (female and male, over 50 years).
• Fractured patients will be obtained at the traumatology service of Fricke Hospital (Viña del Mar) which receives about 350 patients with hip fractures per year.
• Control will be obtained at the community health centers of Valparaiso in collaboration with the UV project Geropolis.

DXA measurement will be done at the imaging center of the Universidad Catolica de Valparaiso (PUCV, FONDEQUIP EQM160142). Additional DXA parameters concerning muscle and fat, will be taken into account.

• Study Type: Observational
• Enrollment (Actual): 50

Contacts and Locations

Study Locations

• Chile
  • Valparaíso, Chile
    • Universidad de Valparaiso

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 50 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

The cohort will be:

Women and men over 50 years old

Description

For both groups:

Inclusion Criteria:

• > 50 years old

Exclusion Criteria:

• History of fracture
• Corticoid treatment
• Renal disease
• Arthritis
• BMI < 15 and > 30
• Double femoral prosthesis

In case group/with fracture is added:

Inclusion criteria

• Recent femoral bone fragility fracture

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Cortical parameter measurement obtained by BDAT (Ultrasound)	Cortical thickness (mm) at one-third distal radius and mid-tibia	Inclusion time
Cortical parameter measurement obtained by BDAT (Ultrasound)	Cortical porosity (%) at one-third distal radius and mid-tibia	Inclusion time
Ultrasonic velocities measurement obtained by BDAT (Ultrasound)	velocity (m.s-1) of the First Arriving Signal (VFAS) at one-third distal radius and mid-tibia	Inclusion time
Ultrasonic velocities measurement obtained by BDAT (Ultrasound)	velocity (m.s-1) of the A0 guided mode (A0) at one-third distal radius and mid-tibia	Inclusion time

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Quality measurement parameter obtained by BDAT (Ultrasound)	measurement at one-third distal radius and mid-tibia, normalized quality parameter (value ranging from 0 to 1).	Inclusion time
femoral aBMD obtained by DXA	measurement of femoral areal Bone Mineral Density (aBMD g.cm-2).	Inclusion time
Body composition measurements obtained by DXA	body composition: body fat, muscle and bone mass (kg).	Inclusion time
10-year probability of fracture provided by FRAX algotithm	10-year probability of a major osteoporotic fracture, calculated with the femoral aBMD value.	Inclusion time
10-year probability of fracture provided by FRAX algotithm	10-year probability of a major osteoporotic fracture, calculated without the femoral aBMD value.	Inclusion time

Collaborators and Investigators

• Sponsor: Universidad de Valparaiso
• Collaborators: Pontificia Universidad Catolica de Valparaiso; Centro Gerópolis UV, Valparaíso; Centro de Salud Familiar Marcelo Mena; Hospital Dr. Gustavo Fricke, Valparaíso
• Investigators: Principal Investigator: Jean-Gabriel Minonzio, Ph.D, Universidad de Valparaiso; Study Chair: José Luis Dinamarca, M.D., Universidad de Valparaiso

Publications and helpful links

Helpful Links

• study using the same ultrasonic device
• The FRAX® algorithms give the 10-year probability of fracture.

Study record dates

Study Major Dates

• Study Start (Actual): July 18, 2022
• Primary Completion (Actual): January 24, 2023
• Study Completion (Actual): January 31, 2024

Study Registration Dates

• First Submitted: June 14, 2022
• First Submitted That Met QC Criteria: June 14, 2022
• First Posted (Actual): June 21, 2022

Study Record Updates

• Last Update Posted (Estimated): January 16, 2026
• Last Update Submitted That Met QC Criteria: January 14, 2026
• Last Verified: January 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Wounds and Injuries; Fractures, Bone; Osteoporotic Fractures; Physical Phenomena; Radiation; Radiation, Nonionizing; Ultrasonic Waves; Sound; High-Energy Shock Waves
• Other Study ID Numbers: 1201311

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No